U.S. PRP And Stem Cell Alopecia Treatment Market Analysis 2025-2030 By Treatment, Indication, And End-Use - Androgenic Alopecia Dominated The Market With A 71.51% Revenue Share In 2024

(MENAFN- GlobeNewsWire - Nasdaq) Increasing Consumer Demand for Non-Invasive and Natural Treatments Driving the Market, Reaching $438.91 Million by 2030

Dublin, Jan. 20, 2025 (GLOBE NEWSWIRE) -- The "U.S. PRP and Stem Cell Alopecia Treatment Market Size, Share & Trends Analysis by Treatment, Indication, and End-use, 2025-2030" report has been added to ResearchAndMarkets.com's offering.

The U.S. PRP and stem cell alopecia treatment market size is anticipated to reach USD 438.91 million by 2030. The market is projected to grow at a CAGR of 9.46% from 2025 to 2030.

Factors contributing to the growth of this market include rise in disease awareness, increased treatment rate, and growing adoption of novel treatment therapies providing a positive patient outcome. Moreover, lower incidence of negative side effects due to this therapy is anticipated to fuel demand for platelet-rich plasma (PRP) and stem cell therapy.

Adoption of PRP and stem cell therapy for alopecia is expected to increase owing to a rise in the number of patients preferring novel therapies over conventional therapies. In addition to this, shorter treatment duration, faster hair regrowth, and improved patient outcome are expected to drive demand for these therapies over the forecast period.
U.S. PRP and Stem Cell Alopecia Treatment Market Report: Highlights

• Stem cell therapy is expected to grow significantly at a CAGR of 12.47% over the forecast period, owing to its promising applications in treating various conditions, including hair loss and degenerative diseases.
• Androgenic alopecia dominated the market and accounted for the largest revenue share of 71.51% in 2024 attributed to its high prevalence, affecting approximately 50 million men and 30 million women.
• Dermatology clinics dominated the market and accounted for the largest revenue share of 69.60% in 2024 driven by the rising prevalence of skin conditions and hair loss disorders, such as androgenic alopecia.

This report addresses:

• Market intelligence to enable effective decision-making
• Market estimates and forecasts from 2018 to 2030
• Growth opportunities and trend analyses
• Segment and regional revenue forecasts for market assessment
• Competition strategy and market share analysis
• Product innovation listing for you to stay ahead of the curve

Key Attributes

Report Attribute	Details
No. of Pages	70
Forecast Period	2024-2030
Estimated Market Value (USD) in 2024	$255.2 Million
Forecasted Market Value (USD) by 2030	$438.91 Million
Compound Annual Growth Rate	9.4%
Regions Covered	United States

Key Topics Covered
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. PRP & Stem Cell Alopecia Treatment Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.1.1 Increasing Prevalence of Alopecia
3.3.1.2 Technological Advancements and Research in Regenerative Medicine
3.3.1.3 Increasing Consumer Demand for Non-Invasive and Natural Treatments
3.3.2. Market Restraints Analysis
3.3.2.1. Regulatory and Legal Barriers
3.3.2.2. High Cost of Treatment and Accessibility Issues
3.3.2.3. Lack of Long-Term Clinical Evidence and Efficacy Data
3.4. U.S. PRP & Stem Cell Alopecia Treatment Market Analysis Tools
3.4.1. Porter's Analysis
3.4.2. PESTEL Analysis

Chapter 4. U.S. PRP & Stem Cell Alopecia Treatment Market: Treatment Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. PRP & Stem Cell Alopecia Treatment Market: Treatment Movement Analysis, 2023 & 2030 (USD Million)
4.3. Platelet Rich Plasma Therapy
4.4. Stem Cell Therapy

Chapter 5. U.S. PRP & Stem Cell Alopecia Treatment Market: Indication Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. PRP & Stem Cell Alopecia Treatment Market: Indication Movement Analysis, 2023 & 2030 (USD Million)
5.3. Androgenic Alopecia
5.4. Alopecia Areata
5.5. Cicatricial or Scarring Alopecia
5.6. Others

Chapter 6. U.S. PRP & Stem Cell Alopecia Treatment Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. PRP & Stem Cell Alopecia Treatment Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
6.3. Hospitals
6.4. Dermatology Clinics
6.5. Others

Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. Bauman Medical Group, P.A.
7.4.2. Virginia Surgical Center
7.4.3. Nova Medical Hair Transplant
7.4.4. Chicago Hair Transplant Clinic
7.4.5. Dr. V Medical Aesthetics
7.4.6. City Facial Plastics
7.4.7. Orange County Hair Restoration
7.4.8. MAXIM Hair Restoration
7.4.9. New Jersey Hair Restoration Center
7.4.10. Hair Restoration Institute of Minnesota
7.4.11. Morgenstern Hair Restoration LLC

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• U.S. PRP And Stem Cell Alopecia Treatment Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN20012025004107003653ID1109107738